DSIP
Delta Sleep-Inducing Peptide
An endogenous nonapeptide first isolated for its association with delta-wave (slow-wave) sleep, studied for sleep modulation and neuroendocrine/stress effects. Its precise mechanism remains incompletely characterized.
Half-life
Short, minutes in plasma (~7-15 min reported); IV or subcutaneous. Half-life is an educational pharmacology figure, drawn from public sources, and is not a schedule or dosing instruction.
Storage & handling
Lyophilized powder kept frozen or refrigerated and protected from light; reconstituted solutions refrigerated, used within a limited window.
References
- DSIP review (PMID 6145137)
- Plasma degradation study (PMID 3628078)
Related in Cognitive / Longevity
Educational reference only, compiled from public sources. Not medical advice, diagnosis, treatment, or a dosing recommendation, and not a recommendation to use any compound. Many compounds listed are research materials not approved for human use. Consult a qualified professional.